Nkarta, Inc. (NKTX)
NASDAQ: NKTX · Real-Time Price · USD
2.790
-0.070 (-2.45%)
At close: Jun 22, 2026, 4:00 PM EDT
2.800
+0.010 (0.36%)
After-hours: Jun 22, 2026, 7:07 PM EDT
Nkarta Market Cap
Nkarta has a market cap or net worth of $199.61 million as of June 22, 2026. Its market cap has increased by 53.72% in one year.
Market Cap
199.61M
Enterprise Value
44.18M
1-Year Change
53.72%
Ranking
Category
Stock Price
$2.79
Market Cap Chart
Since July 10, 2020, Nkarta's market cap has decreased from $1.46B to $199.61M, a decrease of -86.37%. That is a compound annual growth rate of -28.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 22, 2026 | 199.61M | 51.91% |
| Dec 31, 2025 | 131.40M | -25.22% |
| Dec 31, 2024 | 175.72M | -45.75% |
| Dec 29, 2023 | 323.88M | 10.77% |
| Dec 30, 2022 | 292.39M | -42.19% |
| Dec 31, 2021 | 505.77M | -74.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Camp4 Therapeutics | 214.45M |
| Arcturus Therapeutics Holdings | 214.03M |
| Keros Therapeutics | 210.78M |
| Minerva Neurosciences | 208.25M |
| ALX Oncology Holdings | 205.88M |
| Humacyte | 205.23M |
| Karyopharm Therapeutics | 204.42M |
| Q32 Bio | 201.78M |